Publications 2025

Andersen KAA, Holmøy B, Kvam TM, Johnson MW (2025)
Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire
J Psychiatr Res, 189, 18-25 (in press)
DOI 10.1016/j.jpsychires.2025.05.062, PubMed 40466556

Rognli EB, Andersen KAA, Aas EM, Reme SE, Lystad JU, Stavseth MR, Arnevik EA (2025)
The effectiveness of Individual Placement and Support on vocational outcomes for patients with substance use disorders: A pragmatic superiority randomized controlled trial of Individual Placement and Support versus enhanced self-help
Addiction (in press)
DOI 10.1111/add.70155, PubMed 40702951

Tunstad PA, Kvam TM, Uthaug MV, Stewart LH, Andersen KAA, Grønnerød C (2025)
Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample
Front Pharmacol, 16, 1556299
DOI 10.3389/fphar.2025.1556299, PubMed 40276609

Publications 2023

Kvam TM, Uthaug MV, Andersen KAA, Refsum BB, Tunstad PA, Stewart LH, Jacobsen HB, Grønnerød C (2023)
Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample
Front Psychiatry, 14, 1287196
DOI 10.3389/fpsyt.2023.1287196, PubMed 38025484

Publications 2020

Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D (2020)
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies
Acta Psychiatr Scand, 143 (2), 101-118
DOI 10.1111/acps.13249, PubMed 33125716